<DOC>
	<DOCNO>NCT01794884</DOCNO>
	<brief_summary>In view lack large-scale clinical study potent evidence-based medicine , investigator design randomize , double-blind , placebo-controlled study ascertain whether preoperative intravenous administration glutamine improve postoperative cardiac function prognosis adult patient undergoing cardiac surgery . The investigator want detect level myocardial protein O-GlcNAc modification HSP70 expression , change sensitive indicator myocardial injury , systemic inflammatory reaction oxidative stress level , examine correlation change Clinical manifestation . The ultimate goal study explore new way clinical myocardial protection .</brief_summary>
	<brief_title>Validity Study Glutamine Improve Cardiac Function Cardiac Surgery</brief_title>
	<detailed_description>Cardiosurgery mostly do cardiopulmonary bypass . However , cardiopulmonary bypass later recovery spontaneous circulation , cardiac ischemia / reperfusion process , may cause myocardial damage affect cardiac function well prognosis . Glutamine , amino acid abundant human body , play important role regulation metabolism immune cell protection organ . Relative lack glutamine report stress serious illness . Animal study confirm pretreatment glutamine protective effect heart , liver , kidney organ post ischemia / reperfusion injury . It also establish glutamine exerts myocardial protection mainly activate hexosamine biosynthetic pathway , increase intracellular O-GlcNAc protein modification expression heat shock protein 70 ( HSP70 ) , start protective reaction body , improve function myocardial cell , inhibit release inflammatory cytokine oxidative stress level . Besides , clinical study show perioperative stage glutamine protective effect cardiac function patient treat pump coronary artery bypass surgery . The purpose study ascertain whether preoperative intravenous administration glutamine ( compare control group ) improve postoperative cardiac function prognosis adult patient undergoing cardiac surgery reduce inflammatory response oxidative stress level body . The correlation Clinical manifestation expression myocardium O-GlcNAc HSP70 also investigate .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Rheumatic Heart Disease</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Adult patient coronary artery disease rheumatic heart disease accept cardiosurgery cardiopulmonary bypass ejection fraction ( EF ) &lt; 50 % Preoperative support intraaortic balloon pump ( IABP ) Hepatosis Renal dysfunction Myocardial infarction attack within 3 month Emergency operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Glutamine</keyword>
	<keyword>Cardiosurgery</keyword>
	<keyword>Cardiopulmonary bypass</keyword>
	<keyword>Cardiac function</keyword>
	<keyword>Recovery</keyword>
</DOC>